Patents by Inventor Kazuhiro Miwa
Kazuhiro Miwa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240153652Abstract: A core of a fast reactor including a sodium plenum installed above a core fuel, which is capable of reliably reducing a void reactivity, and an operation method thereof are provided. The core of a fast reactor including the sodium plenum installed above the core fuel is characterized in that a tip of a primary control rod is inserted into a core fuel region, and a tip of a backup control rod is arranged above an upper end of the core fuel region for operation.Type: ApplicationFiled: November 13, 2023Publication date: May 9, 2024Inventors: Koji FUJIMURA, Kazuhiro Fujimata, Suo Fuchita, Junichi Miwa
-
Patent number: 11795178Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrirnidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: GrantFiled: March 14, 2022Date of Patent: October 24, 2023Assignee: Takeda Pharmaceutical Company LimitedInventors: Koichiro Fukuoka, Kazuhiro Miwa, Tsuyoshi Sasaki, Fumiya Komura
-
Patent number: 11731983Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: GrantFiled: June 16, 2021Date of Patent: August 22, 2023Assignee: Takeda Pharmaceutical Company LimitedInventor: Kazuhiro Miwa
-
Publication number: 20230212184Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: ApplicationFiled: March 15, 2023Publication date: July 6, 2023Inventors: Koichiro FUKUOKA, Kazuhiro MIWA
-
Publication number: 20220204525Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrirnidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: ApplicationFiled: March 14, 2022Publication date: June 30, 2022Inventors: Koichiro FUKUOKA, Kazuhiro MIWA, Tsuyoshi SASAKI, Fumiya KOMURA
-
Publication number: 20220135585Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: ApplicationFiled: June 16, 2021Publication date: May 5, 2022Inventor: Kazuhiro MIWA
-
Patent number: 11053257Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: GrantFiled: December 11, 2019Date of Patent: July 6, 2021Assignee: Takeda Pharmaceutical Company LimitedInventor: Kazuhiro Miwa
-
Patent number: 10919595Abstract: A hydraulic shock absorber includes a control valve. The control valve includes a valve seat formed with a closing face, a valve body configured to come into contact with the closing face, and a valve shaft configured to transmit an operation force applied from a driving unit to the valve body. The control valve is defined with an upstream side flow channel extending from an inlet coupled to the upper end opening, via a space in which the valve body moves, to the closing face, and a downstream side flow channel extending from the closing face to an outlet. The control valve is disposed above the cylinder so that a central axis of the valve shaft is inclined relative to a central axis of the vehicle body side tube and the wheel side tube.Type: GrantFiled: February 8, 2017Date of Patent: February 16, 2021Assignee: Showa CorporationInventors: Yosuke Murakami, Kazuhiro Miwa, Naoya Kuroiwa
-
Patent number: 10876590Abstract: There is provided a compact damping force variable shock absorber capable of implementing different adjustments for a compression-side stroke and an extension-side stroke as initial settings. A damping force variable device in one embodiment includes: a main valve that opens and closes to control flow of oil caused by sliding of a piston in a cylinder, thereby generating damping force; a pilot chamber into which a portion of the flow of the oil is introduced so that internal pressure is applied to the main valve in a valve-closing direction; a pilot valve that opens and closes to adjust the internal pressure of the pilot chamber; and a communication passage that communicates the pilot chamber with a rod-side oil chamber or a piston-side fluid chamber.Type: GrantFiled: March 20, 2019Date of Patent: December 29, 2020Assignee: Showa CorporationInventors: Kazuhiro Miwa, Naoya Kuroiwa
-
Publication number: 20200361953Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine 2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: ApplicationFiled: December 11, 2019Publication date: November 19, 2020Inventor: Kazuhiro MIWA
-
Patent number: 10763204Abstract: A semiconductor device includes: a semiconductor element; a support as a metallic member that includes a metallized layer having a first component as an iron group element and a second component as a periodic table group five or group six transition metal element other than chromium provided at an outermost surface of the support, and is arranged such that the outermost surface faces the semiconductor element; a joint material that is arranged between the outermost surface of the support and the semiconductor element, and is joined with the outermost surface to fix the semiconductor element to the support; and a molding resin that is arranged to cover a joint body having the support, the joint material and the semiconductor element.Type: GrantFiled: February 25, 2019Date of Patent: September 1, 2020Assignees: DENSO CORPORATION, C. Uyemura & Co., Ltd.Inventors: Tomohito Iwashige, Kazuhiko Sugiura, Kazuhiro Miwa, Yuichi Sakuma, Seigo Kurosaka, Yukinori Oda
-
Patent number: 10544160Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: GrantFiled: August 29, 2018Date of Patent: January 28, 2020Assignee: Takeda Pharmaceutical Company LimitedInventor: Kazuhiro Miwa
-
Patent number: 10464945Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl) -5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine -2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: GrantFiled: July 12, 2018Date of Patent: November 5, 2019Assignee: Takeda Pharmaceutical Company LimitedInventor: Kazuhiro Miwa
-
Patent number: 10428895Abstract: A valve mechanism includes a housing, a plate-shaped valve body, a valve positioning member, and a drive valve moving mechanism. The valve positioning member causes the valve body to face the valve seat via a predetermined gap with respect to the valve seat. The drive valve moving mechanism causes the gap between an inner circumference of the valve body and the valve seat to be variable by moving the drive valve in a direction of approaching the valve seat and elastically deforming the valve body in a direction that the inner circumference of the valve body approaches the valve seat.Type: GrantFiled: September 8, 2016Date of Patent: October 1, 2019Assignee: Showa CorporationInventors: Kazuhiro Miwa, Yosuke Murakami
-
Publication number: 20190219126Abstract: There is provided a compact damping force variable shock absorber capable of implementing different adjustments for a compression-side stroke and an extension-side stroke as initial settings. A damping force variable device in one embodiment includes: a main valve that opens and closes to control flow of oil caused by sliding of a piston in a cylinder, thereby generating damping force; a pilot chamber into which a portion of the flow of the oil is introduced so that internal pressure is applied to the main valve in a valve-closing direction; a pilot valve that opens and closes to adjust the internal pressure of the pilot chamber; and a communication passage that communicates the pilot chamber with a rod-side oil chamber or a piston-side fluid chamber.Type: ApplicationFiled: March 20, 2019Publication date: July 18, 2019Applicant: Showa CorporationInventors: Kazuhiro MIWA, Naoya KUROIWA
-
Publication number: 20190198441Abstract: A semiconductor device includes: a semiconductor element; a support as a metallic member that includes a metallized layer having a first component as an iron group element and a second component as a periodic table group five or group six transition metal element other than chromium provided at an outermost surface of the support, and is arranged such that the outermost surface faces the semiconductor element; a joint material that is arranged between the outermost surface of the support and the semiconductor element, and is joined with the outermost surface to fix the semiconductor element to the support; and a molding resin that is arranged to cover a joint body having the support, the joint material and the semiconductor element.Type: ApplicationFiled: February 25, 2019Publication date: June 27, 2019Inventors: Tomohito IWASHIGE, Kazuhiko SUGIURA, Kazuhiro MIWA, Yuichi SAKUMA, Seigo KUROSAKA, Yukinori ODA
-
Publication number: 20190127016Abstract: A hydraulic shock absorber includes a control valve. The control valve includes a valve seat formed with a closing face, a valve body configured to come into contact with the closing face, and a valve shaft configured to transmit an operation force applied from a driving unit to the valve body. The control valve is defined with an upstream side flow channel extending from an inlet coupled to the upper end opening, via a space in which the valve body moves, to the closing face, and a downstream side flow channel extending from the closing face to an outlet. The control valve is disposed above the cylinder so that a central axis of the valve shaft is inclined relative to a central axis of the vehicle body side tube and the wheel side tube.Type: ApplicationFiled: February 8, 2017Publication date: May 2, 2019Applicant: Showa CorporationInventors: Yosuke MURAKAMI, Kazuhiro MIWA, Naoya KUROIWA
-
Publication number: 20190055261Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: ApplicationFiled: August 29, 2018Publication date: February 21, 2019Inventor: Kazuhiro MIWA
-
Patent number: 10150778Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: GrantFiled: April 7, 2017Date of Patent: December 11, 2018Assignee: Takeda Pharmaceutical Company LimitedInventor: Kazuhiro Miwa
-
Publication number: 20180319816Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.Type: ApplicationFiled: July 12, 2018Publication date: November 8, 2018Inventors: Kazuhiro MIWA, Tsuyoshi SASAKI, Fumiya KOMURA